Suppr超能文献

缓激肽在正常血压和高血压大鼠中的中枢升压作用。

The central pressor effect of bradykinin in normotensive and hypertensive rats.

作者信息

Lindsey C J, Fujita K, Martins T O

机构信息

Department of Biophysics, Paulista School of Medicine, São Paulo, Brazil.

出版信息

Hypertension. 1988 Feb;11(2 Pt 2):I126-9. doi: 10.1161/01.hyp.11.2_pt_2.i126.

Abstract

The site of action for the pressor response to bradykinin administered into the lateral ventricle has been reported to be either in the septal area or in the ventral portion of the third ventricle. We obtained dose-response curves for the pressor effect of bradykinin injected into the lateral ventricle or the posterior region of the fourth ventricle of normotensive Wistar and spontaneously hypertensive rats (SHR). Responses to fourth ventricle injections had a shorter latency and larger maximal effect, and were 20 to 100 times greater than those to lateral ventricle injections, suggesting that the site of bradykinin's action is in the caudal region of the brain, probably close to the area postrema. Maximal effects were similar for lateral and fourth ventricle injections in both SHR and normotensive rats, but SHR were much more sensitive to bradykinin. The ED50 values for the lateral ventricle route in normotensive rats and SHR were 1.3 and 0.35 nmol, respectively, and, for the fourth ventricle route, 60 and 3.4 pmol, respectively. Responses to Lys-Lys-bradykinin, a kininase-resistant bradykinin analogue, showed that kininase activity is lower in SHR than in normotensive rats and that SHR are four times more sensitive to Lys-Lys-bradykinin than are normotensive rats. The responses of all rats were inhibited by a specific bradykinin receptor blocker [Thi5,8,DPhe7]bradykinin. Our results show that there is a site of bradykinin action that is far more caudal than those previously described. The shorter latency and higher sensitivity of the fourth ventricle injection suggest that bradykinin injected into the lateral ventricle diffuses to the fourth ventricle where it exerts its effects.

摘要

据报道,向侧脑室内注射缓激肽所引起的升压反应作用部位,要么在隔区,要么在第三脑室腹侧部分。我们获得了向正常血压的Wistar大鼠和自发性高血压大鼠(SHR)的侧脑室或第四脑室后部注射缓激肽的升压效应剂量-反应曲线。对第四脑室注射的反应潜伏期较短,最大效应较大,比侧脑室注射的反应大20至100倍,这表明缓激肽的作用部位在脑的尾侧区域,可能靠近最后区。在SHR和正常血压大鼠中,侧脑室和第四脑室注射的最大效应相似,但SHR对缓激肽更为敏感。正常血压大鼠和SHR通过侧脑室途径给药的半数有效剂量(ED50)值分别为1.3和0.35 nmol,通过第四脑室途径给药的ED50值分别为60和3.4 pmol。对赖氨酰-赖氨酰-缓激肽(一种对激肽酶有抗性的缓激肽类似物)的反应表明,SHR中的激肽酶活性低于正常血压大鼠,并且SHR对赖氨酰-赖氨酰-缓激肽的敏感性是正常血压大鼠的四倍。所有大鼠的反应均被特异性缓激肽受体阻断剂[Thi5,8,DPhe7]缓激肽抑制。我们的结果表明,存在一个比先前描述的部位更靠尾侧的缓激肽作用部位。第四脑室注射潜伏期较短且敏感性较高,这表明注入侧脑室的缓激肽扩散到第四脑室并在那里发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验